# The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression

> **NCT02849639** · EARLY_PHASE1 · COMPLETED · sponsor: **Daniela Moga** · enrollment: 90 (actual)

## Conditions studied

- Alzheimer's Disease
- Dementia

## Interventions

- **OTHER:** Placebo
- **OTHER:** Medication Therapy Management (MTM)
- **DRUG:** Scopolamine patch

## Key facts

- **NCT ID:** NCT02849639
- **Lead sponsor:** Daniela Moga
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-04
- **Primary completion:** 2021-04-21
- **Final completion:** 2021-04-21
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849639, "The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT02849639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*